Advertisement
Research Article| Volume 10, ISSUE 3, P225-230, October 1988

Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women

  • K. Verbeke
    Affiliations
    Department of Obstetrics and Gynaecology, Rijksuniversiteit Gent, University Hospital Ghent, De Pintelaan 185, B-9000 Ghent, Belgium
    Search for articles by this author
  • M. Dhont
    Affiliations
    Department of Obstetrics and Gynaecology, Rijksuniversiteit Gent, University Hospital Ghent, De Pintelaan 185, B-9000 Ghent, Belgium
    Search for articles by this author
  • D. Vandekerckhove
    Correspondence
    Correspondence to: Prof. D. Vandekerckhove, M.D., Rijksuniversiteit Gent, Gynecologische Kliniek, De Pintelaan 185, 9000 Gent, Belgium.
    Affiliations
    Department of Obstetrics and Gynaecology, Rijksuniversiteit Gent, University Hospital Ghent, De Pintelaan 185, B-9000 Ghent, Belgium
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The clinical and hormonal effects of long-term, continuous treatment with veralipride, a benzamide derivative, were investigated in 10 post-menopausal women. The efficacy of veralipride in relieving hot flushes was confirmed. No significant change was detected in depressive mood scores. Except for the late appearance of moderate extrapyramidal side effects in one patient, the clinical tolerance of veralipride was good. As regards hormonal effects, veralipride, by virtue of its antidopaminergic action, raised prolactin levels. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels declined significantly, while the serum concentration of dehydroepiandrosterone sulphate (DHEAS) increased. These hormonal changes were persumably secondary to the chronic hyperprolactinaemia.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wesel S
        • L'Hermite M
        Etude du véralipride dans le traitement des bouffées de chaleur de la ménopause.
        Sem Hôp. 1980; 56: 37-38
        • Wesel S
        • L'Hermite M
        Etude du véralipride dans le traitement des bouffées de chaleur de la ménopause.
        Sem Hôp. 1980; 56: 1465-1467
        • Pasetto N
        • Piccione E
        • Bashieri L
        Le véralipride dans le traitement des bouffées de chaleur de la ménopause.
        Rev Fr Gynecol Obstet. 1985; 80: 163-165
        • Rebar RW
        • Spitzer IB
        The physiology and measurement of hot flushes.
        Am J Obstet Gynecol. 1987; 156: 1284-1288
        • Tataryn IV
        • Lomax P
        • Bajorek JG
        • Chesarek W
        • Meldrum DR
        • Judd HL
        Postmenopausal hot flushes: a disorder of thermoregulation.
        Maturitas. 1980; 2: 101-107
        • Laufer LR
        • Erlik Y
        • Meldrum DR
        • Judd HL
        Effect of clonidine on hot flushes in postmenopausal women.
        Obstet Gynecol. 1982; 60: 583-586
        • Perrault GH
        • Margarit J
        • Laville CI
        Propriétés antidopaminergiques centrales comparées du véralipride et du sulpiride.
        Rev. Fr Gynecol Obstet. 1981; 76: 655-660
        • Schiebinger RJ
        • Chrousos GP
        • Cutler GB
        • Loriaux DL
        The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
        J Clin Endocrinol Metab. 1986; 62: 202-207
        • Bohnet HG
        • Dahlen HG
        • Wuttke N
        • Schneider HP
        Hyperprolactinemic anovulatory syndrome.
        J Clin Endocrinol Metab. 1976; 42: 132-142
        • Dargent D
        • Dumont M
        • Malinas Y
        Etude de l'efficacité et de la tolérance clinique et biologique due véralipride administré au long cours.
        in: A propos de soixante-quatorze observations. Rev Fr Gynecol Obstet. 80. 1985: 171-173
        • Simpson G
        • Angus JW
        A roting scale for extrapyromidol side effects.
        Acta Psychiatr Scand. 1970;